INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $474,300 | -22.5% | 15,000 | 0.0% | 0.01% | -30.8% |
Q2 2023 | $611,700 | +9.4% | 15,000 | 0.0% | 0.01% | +18.2% |
Q1 2023 | $559,050 | +60.2% | 15,000 | +50.0% | 0.01% | +83.3% |
Q4 2022 | $348,900 | -37.7% | 10,000 | 0.0% | 0.01% | -45.5% |
Q3 2022 | $560,000 | +8.1% | 10,000 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $518,000 | -28.7% | 10,000 | 0.0% | 0.01% | -26.7% |
Q1 2022 | $727,000 | -38.5% | 10,000 | 0.0% | 0.02% | -42.3% |
Q4 2021 | $1,182,000 | -11.9% | 10,000 | 0.0% | 0.03% | -16.1% |
Q3 2021 | $1,342,000 | -17.1% | 10,000 | 0.0% | 0.03% | -6.1% |
Q2 2021 | $1,619,000 | +101.6% | 10,000 | 0.0% | 0.03% | +83.3% |
Q1 2021 | $803,000 | +47.6% | 10,000 | 0.0% | 0.02% | 0.0% |
Q4 2020 | $544,000 | +173.4% | 10,000 | 0.0% | 0.02% | +125.0% |
Q3 2020 | $199,000 | -5.2% | 10,000 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $210,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |